Insight: PD-1/PD-L1 inhibition alone is a limited approach to immunotherapy. Product X uses combination therapy that targets other pathways and removes the limitations of the possibilities immunotherapy brings. 

 

Idea: The current path that oncologists are on is like a seasoned professional or hobbyist using underpowered equipment. Product X gives oncologists the tools that they need to succeed.